Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false question first answered
creator	label
publisher	pref label
tabling member	label

Search

1139376

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:01
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:12 26/07/2019 11:54:03
	hansard heading	Asthma: Health Services
	house id	1
	identifier	277729
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:22:50
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that asthma sufferers are referred for specialist treatment.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277729
	type	WrittenParliamentaryQuestion
	uin	277729
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:22:50
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139373

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:31:54
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:06 26/07/2019 11:46:03
	hansard heading	Asthma: Health Services
	house id	1
	identifier	277728
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:14:08
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking in response to the death of Ella Kissi-Debrah to (a) improve asthma care and (b) monitor and reduce the effect of air pollution on asthma outcomes.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277728
	type	WrittenParliamentaryQuestion
	uin	277728
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:14:08
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139380

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:10
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:20 26/07/2019 11:44:01
	hansard heading	Asthma: Steroid Drugs
	house id	1
	identifier	277733
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:12:38
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safe prescription of oral corticosteroids to treat asthma.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277733
	type	WrittenParliamentaryQuestion
	uin	277733
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:12:38
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139379

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:08
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:18 26/07/2019 11:44:03
	hansard heading	Beta Agonists: Safety
	house id	1
	identifier	277732
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:12:37
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safety of the prescription of short-acting beta agonists.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277732
	type	WrittenParliamentaryQuestion
	uin	277732
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:12:37
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139378

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:16 26/07/2019 11:43:02
	hansard heading	Asthma: Health Services
	house id	1
	identifier	277731
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:11:44
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the number of severe asthma centres.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277731
	type	WrittenParliamentaryQuestion
	uin	277731
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:11:44
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139377

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:14 26/07/2019 11:42:02
	hansard heading	Asthma: Health Services
	house id	1
	identifier	277730
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/07/2019 11:10:56
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June 2019 to Question 257660 on Asthma: Health Services, what assessment he has made of the effectiveness of NHS treatment for people with severe asthma.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277730
	type	WrittenParliamentaryQuestion
	uin	277730
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 26/07/2019 11:10:56
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139402

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:33:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:42:10 25/07/2019 14:51:07
	hansard heading	Medicine: Research
	house id	1
	identifier	277741
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	25/07/2019 14:20:17
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on the adequacy of funding for medical R&D in advance of the Spending Review.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277741
	type	WrittenParliamentaryQuestion
	uin	277741
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 25/07/2019 14:20:17
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139370

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:31:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:40:59 23/07/2019 17:22:02
	hansard heading	Medical Treatments
	house id	1
	identifier	277725
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 16:50:58
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the closure of the Commissioning Support Programme on treatments within NHS England’s Clinical Commissioning Policy programme; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277725
	type	WrittenParliamentaryQuestion
	uin	277725
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 16:50:58
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139369

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:31:44
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:40:57 23/07/2019 17:22:03
	hansard heading	Medical Treatments
	house id	1
	identifier	277724
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 16:50:58
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 April 2019 to Question 236381, what steps NHS England has taken to fill the gap left by the closure of the Commissioning Support Programme for those treatments that are awaiting review by the Clinical Priorities Advisory Group.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277724
	type	WrittenParliamentaryQuestion
	uin	277724
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 16:50:58
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1139381

	human indexable
	published
	registered interest
	answer date	18/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:32:13
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:41:23 23/07/2019 17:21:04
	hansard heading	Cervical Cancer: Research
	house id	1
	identifier	277734
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	23/07/2019 16:49:49
	question text	To ask the Secretary of State for Health and Social Care, if he will take steps to establish a medical consensus on the management of CIN2 cervical cell changes.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 277734
	type	WrittenParliamentaryQuestion
	uin	277734
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction question first answered 23/07/2019 16:49:49
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon